Acorda Therapeutics (ACOR) Tumbles: Stock Goes Down 9.7% - Tale of the Tape
Acorda Therapeutics, Inc. (ACOR) saw a big move last session, as the company’s shares fell by nearly 10% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent downtrend for ACOR, as the stock is now down 19% since Jan 26.
Although this slump was obviously disappointing, the biomedicine/gene company has seen 1 positive revision and its current year earnings consensus has moved higher over the past few weeks. This suggests that the recent slump might be a temporary blip on the radar for ACOR. So make sure to keep an eye on this stock going forward to see if yesterday’s price decline is confirmed by more weakness, or if it can rebound in the weeks ahead.
ACOR currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.
A better-ranked stock in the same sector is Affymetrix Inc. (AFFX) carrying a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
ACORDA THERAPT (ACOR): Free Stock Analysis Report
AFFYMETRIX INC (AFFX): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
